Kilercik Hakan, Akbulut Sami, Elsarawy Ahmed, Aktas Sema, Alkara Utku, Sevmis Sinasi
Department of Anesthesiology and Reanimation, Gaziosmanpasa Hospital, Faculty of Medicine, Istanbul Yeni Yuzyil University, 34010 Istanbul, Turkey.
Department of Surgery and Liver Transplant Institute, Faculty of Medicine, Inonu University, 44280 Istanbul, Turkey.
J Clin Med. 2025 Mar 16;14(6):2005. doi: 10.3390/jcm14062005.
: Living donor liver transplantation (LDLT) is the predominant transplantation technique in regions with low rates of deceased donation. Right-lobe grafting is adopted in most clinical and radiological donor/recipient scenarios. Due to the considerable variations in right-lobe hepatic venous anatomy, many techniques have been used over the years for the purpose of appropriate venous outflow reconstruction during the recipient procedure. In this paper, we present the technical details and consequences of a complex venous outflow reconstruction model (CORM) based on experience, and the long-term patency results obtained using the model. : Data of patients with end-stage liver disease who underwent LDLT between 21 December 2017 and 29 November 2022 were prospectively collected and retrospectively reviewed. The nomenclature of CORM was assigned when three or more hepatic vein anastomoses were performed. Patients with CORM (CORM group; = 69) were compared with non-CORM patients (non-CORM group; = 130) in terms of demographic, pre- and postoperative clinical, and follow-up features. : Sixty-nine recipients had three or more separate outflow reconstructions (RHV, RIHV, and one or more anterior sectoral veins); these constituted the CORM group. The estimated graft volume of the CORM group was significantly lower than that of the non-CORM group (833 vs. 898; = 0.022), and the mean GRWR was also significantly lower (1.1 vs. 1.2; = 0.004). CORM cases showed longer anhepatic phases, as well as longer times for cold and warm ischemia, than non-CORM cases (63 vs. 51 min, 46 vs. 38 min, and 48 vs. 33 min, < 0.001), though no difference was found with respect to total operative duration. There were no statistical differences between the two groups with respect to rates of in-hospital re-exploration, length of ICU stay, or length of total hospital stay. Graft survival rates at 1 year, 3 years, and 5 years were 88.1%, 83.3%, and 83.3%, respectively, in the CORM group, and 82.9%, 80.2%, and 70.6%, respectively, in the non-CORM group ( = 0.167). : Performing three or more CORMs in right-lobe LDLT is not associated with inferior outcomes, either with regard to perioperative variables or to patient and graft outcomes. Right-lobe graft with complex venous anatomy from a living donor should not be a determinant factor for donor exclusion.
活体肝移植(LDLT)是在尸体供肝率较低地区的主要移植技术。在大多数临床和影像学供体/受体情况下均采用右叶移植。由于右叶肝静脉解剖结构存在较大差异,多年来已采用多种技术,以便在受体手术过程中进行适当的静脉流出道重建。在本文中,我们根据经验介绍了一种复杂静脉流出道重建模型(CORM)的技术细节和结果,以及使用该模型获得的长期通畅结果。
前瞻性收集并回顾性分析了2017年12月21日至2022年11月29日期间接受LDLT的终末期肝病患者的数据。当进行三个或更多肝静脉吻合时,指定为CORM命名法。将CORM患者(CORM组;n = 69)与非CORM患者(非CORM组;n = 130)在人口统计学、术前和术后临床以及随访特征方面进行比较。
69例受体进行了三个或更多独立的流出道重建(右肝静脉、右后下肝静脉和一个或多个前叶静脉);这些构成了CORM组。CORM组的估计移植肝体积显著低于非CORM组(833 vs. 898;P = 0.022),平均移植物重量与受体体重比(GRWR)也显著更低(1.1 vs. 1.2;P = 0.004)。与非CORM病例相比,CORM病例的无肝期更长,冷缺血和热缺血时间也更长(63 vs. 51分钟,46 vs. 38分钟,48 vs. 33分钟,P < 0.001),尽管在总手术持续时间方面未发现差异。两组在院内再次探查率、重症监护病房(ICU)住院时间或总住院时间方面无统计学差异。CORM组1年、3年和5年的移植肝生存率分别为88.1%、83.3%和83.3%,非CORM组分别为82.9%、80.2%和70.6%(P = 0.167)。
在右叶LDLT中进行三个或更多CORM与较差的结果无关,无论是在围手术期变量方面,还是在患者和移植肝结果方面。来自活体供体的具有复杂静脉解剖结构的右叶移植物不应成为排除供体的决定因素。